About this trial
Background: Many thyroidectomy patients suffer from postoperative pain that could delay early hospital discharge and place a significant burden on both the patient and the healthcare team. Bilateral intermediate cervical plexus block (ICPB) provides good analgesia for neck surgery, including thyroidectomy. However, the duration of a single-shot nerve block is usually short. Therefore, adjuvants are used in peripheral nerve blocks.
Objectives: To compare the safety and efficacy of dexmedetomidine versus dexamethasone as adjuvants to bupivacaine in ultrasound-guided intermediate cervical plexus block in patients undergoing total thyroidectomy under general anesthesia.
Patients and Methods: This is a randomized, double-blind, phase four, prospective clinical trial; carried out on 60 patients, who were candidates for total thyroidectomy under general anesthesia at our hospital. Patients were randomly allocated into two equal groups; group A, received bilateral ICPB with isobaric bupivacaine plus dexmedetomidine, and group B, received bilateral ICPB with isobaric bupivacaine plus dexamethasone.
Eligibility criteria
Qualifiers
American Society of Anesthesiologists (ASA) physical status ≤ II
Age from 21 to 60 years
Body Mass Index (BMI) ≤ 35 kg/m2
Disqualifiers
ASA physical status > II
Age < 21 years or > 50 years
BMI > 35 kg/m2
Bronchial asthma
Trial design
Treatments tested in this trial
- Dexmedetomidine Hydrochloride
- Dexamethasone Phosphate